SNCA and Parkinson disease: Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in substantia nigra (SN) pars compacta (SNpc), and the appearance of α-synuclein (α-syn) positive aggregates known as Lewy bodies (LBs).